Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer

Journal of Clinical Oncology

Volumn 23, Issue 31, 2005, Pages 7919-7926

  Menon, Usha ^b   Skates, Steven J ^b   Lewis, Sara ^b   Rosenthal, Adam N ^b   Rufford, Barnaby ^b   Sibley, Karen ^b   MacDonald, Nicola ^b   Dawnay, Anne ^b   Jeyarajah, Arjun ^b   Bast Jr , Robert C ^b   Oram, David ^b   Jacobs, Ian J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN;

ADULT; AGE DISTRIBUTION; ALGORITHM; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; POSTMENOPAUSE; PREDICTIVE VALIDITY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TRANSVAGINAL ECHOGRAPHY; FEASIBILITY STUDY; MASS SCREENING; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; OVARY TUMOR; PROGNOSIS; RISK FACTOR; UNITED KINGDOM; UNITED STATES;

ALGORITHMS; CA-125 ANTIGEN; FEASIBILITY STUDIES; FEMALE; GREAT BRITAIN; HUMANS; MASS SCREENING; MIDDLE AGED; OVARIAN NEOPLASMS; POSTMENOPAUSE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 32944462043     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.01.6642     Document Type: Article

References (19)

1. Jacobs I, Davies AP, Bridges J, et al: Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography. BMJ 306:1030-1034, 1993
2. Jacobs I, Stabile I, Bridges J, et al: Multi-modal approach to screening for ovarian cancer. Lancet 1:268-271, 1988
3. Jacobs IJ, Skates SJ, MacDonald N, et al: Screening for ovarian cancer: A pilot randomized controlled trial. Lancet 353:1207-1210, 1999
4. Skates SJ, Menon U, MacDonald N, et al: Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women. J Clin Oncol 21:206-210, 2003
5. Skates SJ, Pauler DK, Jacobs IJ: Screening based on the risk of cancer calculation from Bayesian hierarchical change point and mixture models of longitudinal markers. J Am Stat Assoc 96:429-435, 2001
6. Menon U, Talaat A, Jeyarajah AR, et al: Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation. Br J Cancer 80:1644-1647, 1999
7. Menon U, Talaat A, Rosenthal AN, et al: Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening. BJOG 107:165-169, 2000
8. Einhorn N, Sjovall K, Knapp RC, et al: Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer. Obstet Gynecol 80:14-18, 1992
9. Deavers MT, Gershenson DM, Tortolero-Luna G, et al: Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential: A study of 99 advanced stage cases. Am J Surg Pathol 26:1129-1141, 2002
10. Sjovall K, Nilsson B, Einhorn N: The significance of serum CA 125 elevation in malignant and nonmalignant diseases. Gynecol Oncol 85:175-178, 2002
11. van Nagell JR Jr, DePriest PD, Reedy MB, et al: The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer. Gynecol Oncol 77:350-356, 2000
12. Sato S, Yokoyama Y, Sakamoto T, et al: Usefulness of mass screening for ovarian carcinoma using transvaginal ultrasonography. Cancer 89:582-588, 2000
13. Gohagan JK, Prorok PC, Hayes RB, et al: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: History, organization, and status. Control Clin Trials 21:251S-272S, 2000
14. Hartge P, Hayes R, Sherman M, et al: Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors. Preliminary data from the PLCO cancer screening trial. Ann Epidemiol 10:465, 2000
15. Hasson MA, Fagerstrom RM, Kahane DC, et al: Design and evolution of the data management systems in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 21:3293-3485, 2000
16. Hayes RB, Reding D, Kopp W, et al: Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials 21:349S-355S, 2000
17. Miller AB, Yurgalevitch S, Weissfeld JL: Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 21:400S-406S, 2000
18. O'Brien B, Nichaman L, Browne JE, et al: Coordination and management of a large multicenter screening trial: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 21:310S-328S, 2000
19. Prorok PC, Andriole GL, Bresalier RS, et al: Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 21:273S-309S, 2000